Global Acute Kidney Injury Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Acute Kidney Injury Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Kidney Injury Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Kidney Injury Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Kidney Injury Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Kidney Injury Drugs players cover Quark Pharmaceuticals, Baxter International, Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical, B. Braun Melsungen AG and Angion Biomedica Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Acute Kidney Injury Drugs Industry Forecast” looks at past sales and reviews total world Acute Kidney Injury Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Kidney Injury Drugs sales for 2023 through 2029. With Acute Kidney Injury Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Kidney Injury Drugs industry.
This Insight Report provides a comprehensive analysis of the global Acute Kidney Injury Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Kidney Injury Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Acute Kidney Injury Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Kidney Injury Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Kidney Injury Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Kidney Injury Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Acute Kidney Injury Drugs market?
What factors are driving Acute Kidney Injury Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acute Kidney Injury Drugs market opportunities vary by end market size?
How does Acute Kidney Injury Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Acute Kidney Injury Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Kidney Injury Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Kidney Injury Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Kidney Injury Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Kidney Injury Drugs players cover Quark Pharmaceuticals, Baxter International, Fresenius Medical Care AG & Co. KGaA, LG Chem, Asahi Kasei Medical, B. Braun Melsungen AG and Angion Biomedica Corp, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Acute Kidney Injury Drugs Industry Forecast” looks at past sales and reviews total world Acute Kidney Injury Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Kidney Injury Drugs sales for 2023 through 2029. With Acute Kidney Injury Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Kidney Injury Drugs industry.
This Insight Report provides a comprehensive analysis of the global Acute Kidney Injury Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Kidney Injury Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Acute Kidney Injury Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Kidney Injury Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Kidney Injury Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Kidney Injury Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Prerenal Acute Kidney Injury
- Postrenal Acute Kidney Injury
- Intrinsic Acute Kidney Injury
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Quark Pharmaceuticals
- Baxter International
- Fresenius Medical Care AG & Co. KGaA
- LG Chem
- Asahi Kasei Medical
- B. Braun Melsungen AG
- Angion Biomedica Corp
What is the 10-year outlook for the global Acute Kidney Injury Drugs market?
What factors are driving Acute Kidney Injury Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acute Kidney Injury Drugs market opportunities vary by end market size?
How does Acute Kidney Injury Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Kidney Injury Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Acute Kidney Injury Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Acute Kidney Injury Drugs by Country/Region, 2018, 2022 & 2029
2.2 Acute Kidney Injury Drugs Segment by Type
2.2.1 Prerenal Acute Kidney Injury
2.2.2 Postrenal Acute Kidney Injury
2.2.3 Intrinsic Acute Kidney Injury
2.2.4 Others
2.3 Acute Kidney Injury Drugs Sales by Type
2.3.1 Global Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Acute Kidney Injury Drugs Sale Price by Type (2018-2023)
2.4 Acute Kidney Injury Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Acute Kidney Injury Drugs Sales by Application
2.5.1 Global Acute Kidney Injury Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Acute Kidney Injury Drugs Sale Price by Application (2018-2023)
3 GLOBAL ACUTE KIDNEY INJURY DRUGS BY COMPANY
3.1 Global Acute Kidney Injury Drugs Breakdown Data by Company
3.1.1 Global Acute Kidney Injury Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Acute Kidney Injury Drugs Sales Market Share by Company (2018-2023)
3.2 Global Acute Kidney Injury Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Acute Kidney Injury Drugs Revenue by Company (2018-2023)
3.2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Acute Kidney Injury Drugs Sale Price by Company
3.4 Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acute Kidney Injury Drugs Product Location Distribution
3.4.2 Players Acute Kidney Injury Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Acute Kidney Injury Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Acute Kidney Injury Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Acute Kidney Injury Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Acute Kidney Injury Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Acute Kidney Injury Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Acute Kidney Injury Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Acute Kidney Injury Drugs Sales Growth
4.4 APAC Acute Kidney Injury Drugs Sales Growth
4.5 Europe Acute Kidney Injury Drugs Sales Growth
4.6 Middle East & Africa Acute Kidney Injury Drugs Sales Growth
5 AMERICAS
5.1 Americas Acute Kidney Injury Drugs Sales by Country
5.1.1 Americas Acute Kidney Injury Drugs Sales by Country (2018-2023)
5.1.2 Americas Acute Kidney Injury Drugs Revenue by Country (2018-2023)
5.2 Americas Acute Kidney Injury Drugs Sales by Type
5.3 Americas Acute Kidney Injury Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Kidney Injury Drugs Sales by Region
6.1.1 APAC Acute Kidney Injury Drugs Sales by Region (2018-2023)
6.1.2 APAC Acute Kidney Injury Drugs Revenue by Region (2018-2023)
6.2 APAC Acute Kidney Injury Drugs Sales by Type
6.3 APAC Acute Kidney Injury Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acute Kidney Injury Drugs by Country
7.1.1 Europe Acute Kidney Injury Drugs Sales by Country (2018-2023)
7.1.2 Europe Acute Kidney Injury Drugs Revenue by Country (2018-2023)
7.2 Europe Acute Kidney Injury Drugs Sales by Type
7.3 Europe Acute Kidney Injury Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Kidney Injury Drugs by Country
8.1.1 Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Acute Kidney Injury Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Acute Kidney Injury Drugs Sales by Type
8.3 Middle East & Africa Acute Kidney Injury Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs
10.3 Manufacturing Process Analysis of Acute Kidney Injury Drugs
10.4 Industry Chain Structure of Acute Kidney Injury Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acute Kidney Injury Drugs Distributors
11.3 Acute Kidney Injury Drugs Customer
12 WORLD FORECAST REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
12.1 Global Acute Kidney Injury Drugs Market Size Forecast by Region
12.1.1 Global Acute Kidney Injury Drugs Forecast by Region (2024-2029)
12.1.2 Global Acute Kidney Injury Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Acute Kidney Injury Drugs Forecast by Type
12.7 Global Acute Kidney Injury Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Quark Pharmaceuticals
13.1.1 Quark Pharmaceuticals Company Information
13.1.2 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
13.1.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Quark Pharmaceuticals Main Business Overview
13.1.5 Quark Pharmaceuticals Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
13.2.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Fresenius Medical Care AG & Co. KGaA
13.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
13.3.2 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
13.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Fresenius Medical Care AG & Co. KGaA Main Business Overview
13.3.5 Fresenius Medical Care AG & Co. KGaA Latest Developments
13.4 LG Chem
13.4.1 LG Chem Company Information
13.4.2 LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
13.4.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LG Chem Main Business Overview
13.4.5 LG Chem Latest Developments
13.5 Asahi Kasei Medical
13.5.1 Asahi Kasei Medical Company Information
13.5.2 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
13.5.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Asahi Kasei Medical Main Business Overview
13.5.5 Asahi Kasei Medical Latest Developments
13.6 B. Braun Melsungen AG
13.6.1 B. Braun Melsungen AG Company Information
13.6.2 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
13.6.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 B. Braun Melsungen AG Main Business Overview
13.6.5 B. Braun Melsungen AG Latest Developments
13.7 Angion Biomedica Corp
13.7.1 Angion Biomedica Corp Company Information
13.7.2 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
13.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Angion Biomedica Corp Main Business Overview
13.7.5 Angion Biomedica Corp Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Kidney Injury Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Acute Kidney Injury Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Acute Kidney Injury Drugs by Country/Region, 2018, 2022 & 2029
2.2 Acute Kidney Injury Drugs Segment by Type
2.2.1 Prerenal Acute Kidney Injury
2.2.2 Postrenal Acute Kidney Injury
2.2.3 Intrinsic Acute Kidney Injury
2.2.4 Others
2.3 Acute Kidney Injury Drugs Sales by Type
2.3.1 Global Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Acute Kidney Injury Drugs Sale Price by Type (2018-2023)
2.4 Acute Kidney Injury Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Acute Kidney Injury Drugs Sales by Application
2.5.1 Global Acute Kidney Injury Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Acute Kidney Injury Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Acute Kidney Injury Drugs Sale Price by Application (2018-2023)
3 GLOBAL ACUTE KIDNEY INJURY DRUGS BY COMPANY
3.1 Global Acute Kidney Injury Drugs Breakdown Data by Company
3.1.1 Global Acute Kidney Injury Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Acute Kidney Injury Drugs Sales Market Share by Company (2018-2023)
3.2 Global Acute Kidney Injury Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Acute Kidney Injury Drugs Revenue by Company (2018-2023)
3.2.2 Global Acute Kidney Injury Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Acute Kidney Injury Drugs Sale Price by Company
3.4 Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acute Kidney Injury Drugs Product Location Distribution
3.4.2 Players Acute Kidney Injury Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Acute Kidney Injury Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Acute Kidney Injury Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Acute Kidney Injury Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Acute Kidney Injury Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Acute Kidney Injury Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Acute Kidney Injury Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Acute Kidney Injury Drugs Sales Growth
4.4 APAC Acute Kidney Injury Drugs Sales Growth
4.5 Europe Acute Kidney Injury Drugs Sales Growth
4.6 Middle East & Africa Acute Kidney Injury Drugs Sales Growth
5 AMERICAS
5.1 Americas Acute Kidney Injury Drugs Sales by Country
5.1.1 Americas Acute Kidney Injury Drugs Sales by Country (2018-2023)
5.1.2 Americas Acute Kidney Injury Drugs Revenue by Country (2018-2023)
5.2 Americas Acute Kidney Injury Drugs Sales by Type
5.3 Americas Acute Kidney Injury Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Kidney Injury Drugs Sales by Region
6.1.1 APAC Acute Kidney Injury Drugs Sales by Region (2018-2023)
6.1.2 APAC Acute Kidney Injury Drugs Revenue by Region (2018-2023)
6.2 APAC Acute Kidney Injury Drugs Sales by Type
6.3 APAC Acute Kidney Injury Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Acute Kidney Injury Drugs by Country
7.1.1 Europe Acute Kidney Injury Drugs Sales by Country (2018-2023)
7.1.2 Europe Acute Kidney Injury Drugs Revenue by Country (2018-2023)
7.2 Europe Acute Kidney Injury Drugs Sales by Type
7.3 Europe Acute Kidney Injury Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Kidney Injury Drugs by Country
8.1.1 Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Acute Kidney Injury Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Acute Kidney Injury Drugs Sales by Type
8.3 Middle East & Africa Acute Kidney Injury Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs
10.3 Manufacturing Process Analysis of Acute Kidney Injury Drugs
10.4 Industry Chain Structure of Acute Kidney Injury Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acute Kidney Injury Drugs Distributors
11.3 Acute Kidney Injury Drugs Customer
12 WORLD FORECAST REVIEW FOR ACUTE KIDNEY INJURY DRUGS BY GEOGRAPHIC REGION
12.1 Global Acute Kidney Injury Drugs Market Size Forecast by Region
12.1.1 Global Acute Kidney Injury Drugs Forecast by Region (2024-2029)
12.1.2 Global Acute Kidney Injury Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Acute Kidney Injury Drugs Forecast by Type
12.7 Global Acute Kidney Injury Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Quark Pharmaceuticals
13.1.1 Quark Pharmaceuticals Company Information
13.1.2 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
13.1.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Quark Pharmaceuticals Main Business Overview
13.1.5 Quark Pharmaceuticals Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
13.2.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Fresenius Medical Care AG & Co. KGaA
13.3.1 Fresenius Medical Care AG & Co. KGaA Company Information
13.3.2 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
13.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Fresenius Medical Care AG & Co. KGaA Main Business Overview
13.3.5 Fresenius Medical Care AG & Co. KGaA Latest Developments
13.4 LG Chem
13.4.1 LG Chem Company Information
13.4.2 LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
13.4.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LG Chem Main Business Overview
13.4.5 LG Chem Latest Developments
13.5 Asahi Kasei Medical
13.5.1 Asahi Kasei Medical Company Information
13.5.2 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
13.5.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Asahi Kasei Medical Main Business Overview
13.5.5 Asahi Kasei Medical Latest Developments
13.6 B. Braun Melsungen AG
13.6.1 B. Braun Melsungen AG Company Information
13.6.2 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
13.6.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 B. Braun Melsungen AG Main Business Overview
13.6.5 B. Braun Melsungen AG Latest Developments
13.7 Angion Biomedica Corp
13.7.1 Angion Biomedica Corp Company Information
13.7.2 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
13.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Angion Biomedica Corp Main Business Overview
13.7.5 Angion Biomedica Corp Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acute Kidney Injury Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Acute Kidney Injury Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prerenal Acute Kidney Injury
Table 4. Major Players of Postrenal Acute Kidney Injury
Table 5. Major Players of Intrinsic Acute Kidney Injury
Table 6. Major Players of Others
Table 7. Global Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Acute Kidney Injury Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Acute Kidney Injury Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Acute Kidney Injury Drugs Revenue by Application (2018-2023)
Table 15. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Acute Kidney Injury Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Acute Kidney Injury Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Acute Kidney Injury Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Acute Kidney Injury Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Acute Kidney Injury Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Acute Kidney Injury Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution and Sales Area
Table 23. Players Acute Kidney Injury Drugs Products Offered
Table 24. Acute Kidney Injury Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Acute Kidney Injury Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Acute Kidney Injury Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Acute Kidney Injury Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Acute Kidney Injury Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Acute Kidney Injury Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Acute Kidney Injury Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Acute Kidney Injury Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Acute Kidney Injury Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Acute Kidney Injury Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Acute Kidney Injury Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Acute Kidney Injury Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Acute Kidney Injury Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Acute Kidney Injury Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Acute Kidney Injury Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Acute Kidney Injury Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Acute Kidney Injury Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Acute Kidney Injury Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Acute Kidney Injury Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Acute Kidney Injury Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Acute Kidney Injury Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Acute Kidney Injury Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Acute Kidney Injury Drugs
Table 60. Key Market Challenges & Risks of Acute Kidney Injury Drugs
Table 61. Key Industry Trends of Acute Kidney Injury Drugs
Table 62. Acute Kidney Injury Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Acute Kidney Injury Drugs Distributors List
Table 65. Acute Kidney Injury Drugs Customer List
Table 66. Global Acute Kidney Injury Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Acute Kidney Injury Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Acute Kidney Injury Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Acute Kidney Injury Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Acute Kidney Injury Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Acute Kidney Injury Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Acute Kidney Injury Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Acute Kidney Injury Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Acute Kidney Injury Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Acute Kidney Injury Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Acute Kidney Injury Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Acute Kidney Injury Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Acute Kidney Injury Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Acute Kidney Injury Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Quark Pharmaceuticals Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 82. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Quark Pharmaceuticals Main Business
Table 84. Quark Pharmaceuticals Latest Developments
Table 85. Baxter International Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 87. Baxter International Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Baxter International Main Business
Table 89. Baxter International Latest Developments
Table 90. Fresenius Medical Care AG & Co. KGaA Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 92. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Fresenius Medical Care AG & Co. KGaA Main Business
Table 94. Fresenius Medical Care AG & Co. KGaA Latest Developments
Table 95. LG Chem Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 97. LG Chem Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. LG Chem Main Business
Table 99. LG Chem Latest Developments
Table 100. Asahi Kasei Medical Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 102. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Asahi Kasei Medical Main Business
Table 104. Asahi Kasei Medical Latest Developments
Table 105. B. Braun Melsungen AG Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 107. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. B. Braun Melsungen AG Main Business
Table 109. B. Braun Melsungen AG Latest Developments
Table 110. Angion Biomedica Corp Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 112. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Angion Biomedica Corp Main Business
Table 114. Angion Biomedica Corp Latest Developments
Table 1. Acute Kidney Injury Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Acute Kidney Injury Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prerenal Acute Kidney Injury
Table 4. Major Players of Postrenal Acute Kidney Injury
Table 5. Major Players of Intrinsic Acute Kidney Injury
Table 6. Major Players of Others
Table 7. Global Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Acute Kidney Injury Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Acute Kidney Injury Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Acute Kidney Injury Drugs Revenue by Application (2018-2023)
Table 15. Global Acute Kidney Injury Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Acute Kidney Injury Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Acute Kidney Injury Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Acute Kidney Injury Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Acute Kidney Injury Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Acute Kidney Injury Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Acute Kidney Injury Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Acute Kidney Injury Drugs Producing Area Distribution and Sales Area
Table 23. Players Acute Kidney Injury Drugs Products Offered
Table 24. Acute Kidney Injury Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Acute Kidney Injury Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Acute Kidney Injury Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Acute Kidney Injury Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Acute Kidney Injury Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Acute Kidney Injury Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Acute Kidney Injury Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Acute Kidney Injury Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Acute Kidney Injury Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Acute Kidney Injury Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Acute Kidney Injury Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Acute Kidney Injury Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Acute Kidney Injury Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Acute Kidney Injury Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Acute Kidney Injury Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Acute Kidney Injury Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Acute Kidney Injury Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Acute Kidney Injury Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Acute Kidney Injury Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Acute Kidney Injury Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Acute Kidney Injury Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Acute Kidney Injury Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Acute Kidney Injury Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Acute Kidney Injury Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Acute Kidney Injury Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Acute Kidney Injury Drugs
Table 60. Key Market Challenges & Risks of Acute Kidney Injury Drugs
Table 61. Key Industry Trends of Acute Kidney Injury Drugs
Table 62. Acute Kidney Injury Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Acute Kidney Injury Drugs Distributors List
Table 65. Acute Kidney Injury Drugs Customer List
Table 66. Global Acute Kidney Injury Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Acute Kidney Injury Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Acute Kidney Injury Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Acute Kidney Injury Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Acute Kidney Injury Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Acute Kidney Injury Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Acute Kidney Injury Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Acute Kidney Injury Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Acute Kidney Injury Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Acute Kidney Injury Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Acute Kidney Injury Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Acute Kidney Injury Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Acute Kidney Injury Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Acute Kidney Injury Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Quark Pharmaceuticals Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 82. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Quark Pharmaceuticals Main Business
Table 84. Quark Pharmaceuticals Latest Developments
Table 85. Baxter International Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Baxter International Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 87. Baxter International Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Baxter International Main Business
Table 89. Baxter International Latest Developments
Table 90. Fresenius Medical Care AG & Co. KGaA Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 92. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Fresenius Medical Care AG & Co. KGaA Main Business
Table 94. Fresenius Medical Care AG & Co. KGaA Latest Developments
Table 95. LG Chem Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. LG Chem Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 97. LG Chem Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. LG Chem Main Business
Table 99. LG Chem Latest Developments
Table 100. Asahi Kasei Medical Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 102. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Asahi Kasei Medical Main Business
Table 104. Asahi Kasei Medical Latest Developments
Table 105. B. Braun Melsungen AG Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 107. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. B. Braun Melsungen AG Main Business
Table 109. B. Braun Melsungen AG Latest Developments
Table 110. Angion Biomedica Corp Basic Information, Acute Kidney Injury Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolios and Specifications
Table 112. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Angion Biomedica Corp Main Business
Table 114. Angion Biomedica Corp Latest Developments
LIST OF FIGURES
Figure 1. Picture of Acute Kidney Injury Drugs
Figure 2. Acute Kidney Injury Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acute Kidney Injury Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Acute Kidney Injury Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Acute Kidney Injury Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prerenal Acute Kidney Injury
Figure 10. Product Picture of Postrenal Acute Kidney Injury
Figure 11. Product Picture of Intrinsic Acute Kidney Injury
Figure 12. Product Picture of Others
Figure 13. Global Acute Kidney Injury Drugs Sales Market Share by Type in 2022
Figure 14. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Acute Kidney Injury Drugs Consumed in Hospital
Figure 16. Global Acute Kidney Injury Drugs Market: Hospital (2018-2023) & (K Units)
Figure 17. Acute Kidney Injury Drugs Consumed in Clinic
Figure 18. Global Acute Kidney Injury Drugs Market: Clinic (2018-2023) & (K Units)
Figure 19. Global Acute Kidney Injury Drugs Sales Market Share by Application (2022)
Figure 20. Global Acute Kidney Injury Drugs Revenue Market Share by Application in 2022
Figure 21. Acute Kidney Injury Drugs Sales Market by Company in 2022 (K Units)
Figure 22. Global Acute Kidney Injury Drugs Sales Market Share by Company in 2022
Figure 23. Acute Kidney Injury Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Acute Kidney Injury Drugs Revenue Market Share by Company in 2022
Figure 25. Global Acute Kidney Injury Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 28. Americas Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 30. APAC Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 32. Europe Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Acute Kidney Injury Drugs Sales Market Share by Country in 2022
Figure 36. Americas Acute Kidney Injury Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Acute Kidney Injury Drugs Sales Market Share by Region in 2022
Figure 44. APAC Acute Kidney Injury Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Acute Kidney Injury Drugs Sales Market Share by Country in 2022
Figure 55. Europe Acute Kidney Injury Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Acute Kidney Injury Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs in 2022
Figure 73. Manufacturing Process Analysis of Acute Kidney Injury Drugs
Figure 74. Industry Chain Structure of Acute Kidney Injury Drugs
Figure 75. Channels of Distribution
Figure 76. Global Acute Kidney Injury Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Acute Kidney Injury Drugs
Figure 2. Acute Kidney Injury Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acute Kidney Injury Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Acute Kidney Injury Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Acute Kidney Injury Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prerenal Acute Kidney Injury
Figure 10. Product Picture of Postrenal Acute Kidney Injury
Figure 11. Product Picture of Intrinsic Acute Kidney Injury
Figure 12. Product Picture of Others
Figure 13. Global Acute Kidney Injury Drugs Sales Market Share by Type in 2022
Figure 14. Global Acute Kidney Injury Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Acute Kidney Injury Drugs Consumed in Hospital
Figure 16. Global Acute Kidney Injury Drugs Market: Hospital (2018-2023) & (K Units)
Figure 17. Acute Kidney Injury Drugs Consumed in Clinic
Figure 18. Global Acute Kidney Injury Drugs Market: Clinic (2018-2023) & (K Units)
Figure 19. Global Acute Kidney Injury Drugs Sales Market Share by Application (2022)
Figure 20. Global Acute Kidney Injury Drugs Revenue Market Share by Application in 2022
Figure 21. Acute Kidney Injury Drugs Sales Market by Company in 2022 (K Units)
Figure 22. Global Acute Kidney Injury Drugs Sales Market Share by Company in 2022
Figure 23. Acute Kidney Injury Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Acute Kidney Injury Drugs Revenue Market Share by Company in 2022
Figure 25. Global Acute Kidney Injury Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Acute Kidney Injury Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 28. Americas Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 30. APAC Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 32. Europe Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Acute Kidney Injury Drugs Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Acute Kidney Injury Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Acute Kidney Injury Drugs Sales Market Share by Country in 2022
Figure 36. Americas Acute Kidney Injury Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Acute Kidney Injury Drugs Sales Market Share by Region in 2022
Figure 44. APAC Acute Kidney Injury Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Acute Kidney Injury Drugs Sales Market Share by Country in 2022
Figure 55. Europe Acute Kidney Injury Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Acute Kidney Injury Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Acute Kidney Injury Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Acute Kidney Injury Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Acute Kidney Injury Drugs in 2022
Figure 73. Manufacturing Process Analysis of Acute Kidney Injury Drugs
Figure 74. Industry Chain Structure of Acute Kidney Injury Drugs
Figure 75. Channels of Distribution
Figure 76. Global Acute Kidney Injury Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Acute Kidney Injury Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Acute Kidney Injury Drugs Revenue Market Share Forecast by Application (2024-2029)
